Alio develops a remote patient monitoring technology to facilitate better care and reduce avoidable hospitalizations.
Alio has raised $18.0M in total funding. The most recent round was Series C. The last funding was announced in December 2022.
Alio's investors include Dreamit Ventures, Maryland Venture Fund, Zekavat Investment Group, MedTech Innovator, THE CATALYTIC IMPACT FOUNDATION (CIF).
Alio is headquartered in Broomfield, United States.
Alio develops a remote patient monitoring technology to facilitate better care and reduce avoidable hospitalizations.
Alio is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Alio — Funding & Investors." VCBacked, December 8, 2022, https://www.vcbacked.co/company/alio. Accessed September 30, 2026.
VCBacked. (2022). Alio — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/alio
{{cite web |title=Alio — Funding & Investors |url=https://www.vcbacked.co/company/alio |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated